Webinar: COVID-19 and Anti-thrombotic Treatment (Friday, May 29, 2020)
The Global Surgery Foundation is is excited to announce the next installation of Operation Smile’s COVID-19 Rapid Response Webinars:
"COVID-19 and Anti-thrombotic Treatment."
This session is scheduled from 9:00am to 10:30am EDT on Friday, May 29.
A global consensus is starting to form that the major cause of morbidity and mortality from COVID-19 is hypercoagulopathy rather than classic Adult Respiratory Distress Syndrome (ARDS). This realization is starting to transform medicine’s understanding of the COVID-19 disease process and the best approaches to treatment at all stages of the disease, both in the hospital and in the community.
Operation Smile has gathered experts in COVID-19 care and in hematology to discuss the latest findings in COVID-19 hypercoagulopathy and anti-thrombotic treatment. The small panel format is designed to allow ample time for audience Q&A and discussion. It is hoped that participants will gain a better understand of the pathophysiology of COVID-19 hypercoagulopathy and the risks and benefits of putting COVID-19 patients on anti-thrombotic treatment.
Moderator:
Dr. Kate Tulenko, Operation Smile Consultant
Co-Moderator:
Dr. Mark Crowther, Hematologist and Chair of the Department of Medicine at McMaster University in Hamilton, Ontario
Panelists:
Dr. Francesco Violi, Internist and Professor at University of Rome La Sapienza, Rome, Italy
Dr. Jeffrey Laurence, Hematologist and Professor at the Weill Cornell Medical College, New York, USA
Dr. Mark Crowther, Hematologist and Chair of the Department of Medicine at McMaster University in Hamilton, Ontario, Canada